Navaporn Worasilchai Selected Research

Pythiosis

3/2022	A Review: Antimicrobial Therapy for Human Pythiosis.
2/2021	Clinical Outcomes of Radical Surgery and Antimicrobial Agents in Vascular Pythiosis: A Multicenter Prospective Study.
10/2020	Human Pythiosis: Emergence of Fungal-Like Organism.
1/2020	In Vitro Susceptibility of Thai Pythium insidiosum Isolates to Antibacterial Agents.
11/2019	Adjunctive antibacterial agents as a salvage therapy in relapsed vascular pythiosis patients.
11/2019	Clinical outcomes in ocular pythiosis patients treated with a combination therapy protocol in Thailand: A prospective study.
2/2018	Differential diagnosis for pythiosis using thermophilic helicase DNA amplification and restriction fragment length polymorphism (tHDA-RFLP).
1/2018	Monitoring Anti-Pythium insidiosum IgG Antibodies and (1→3)-β-d-Glucan in Vascular Pythiosis.
1/2015	Treatment outcomes of surgery, antifungal therapy and immunotherapy in ocular and vascular human pythiosis: a retrospective study of 18 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Navaporn Worasilchai Research Topics

Disease

9	Pythiosis 03/2022 - 01/2015
6	Sepsis (Septicemia) 01/2020 - 08/2015
3	Candidemia 01/2018 - 08/2015
2	COVID-19 01/2022 - 12/2020
2	Thalassemia 11/2021 - 10/2020
2	Keratitis 01/2021 - 10/2020
2	Peritonitis 07/2016 - 05/2015
1	talaromycosis 12/2021
1	Pneumonia (Pneumonitis) 12/2020
1	Endophthalmitis (Ophthalmia) 10/2020
1	Dysbiosis 01/2020
1	Colitis 01/2020
1	Septic Shock (Toxic Shock Syndrome) 11/2016
1	Endotoxemia 11/2016
1	Foreign Bodies (Foreign Body) 07/2016
1	Flushing 07/2016
1	Bacteremia 01/2016
1	Mycoses (Diseases, Fungus) 01/2016
1	Systemic candidiasis 08/2015
1	Infections 11/2014
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2014

Drug/Important Bio-Agent (IBA)

3	Dextran SulfateIBA 01/2020 - 11/2016
3	SolutionsIBA 01/2020 - 11/2016
3	Biomarkers (Surrogate Marker)IBA 11/2016 - 05/2015
2	CytokinesIBA 01/2022 - 01/2017
2	Pharmaceutical PreparationsIBA 12/2021 - 08/2015
2	Azithromycin (Zithromax)FDA LinkGeneric 02/2021 - 10/2020
2	polyglucosanIBA 02/2021 - 10/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 11/2019
2	Antifungal AgentsIBA 01/2020 - 01/2015
2	EndotoxinsIBA 01/2018 - 11/2016
2	fluorescein isothiocyanate dextranIBA 11/2016 - 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	arginine deiminaseIBA 01/2022
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2022
1	Itraconazole (Sporanox)FDA LinkGeneric 12/2021
1	hydroxide ionIBA 12/2021
1	hydroxyitraconazoleIBA 12/2021
1	efavirenz (Sustiva)FDA Link 12/2021
1	Capsules (Microcapsules)IBA 12/2021
1	Hemoglobin EIBA 11/2021
1	Anti-Infective Agents (Microbicides)IBA 02/2021
1	Doxycycline (Periostat)FDA LinkGeneric 02/2021
1	Bacterial DNAIBA 12/2020
1	Clarithromycin (Biaxin)FDA LinkGeneric 10/2020
1	DNA HelicasesIBA 02/2018
1	AntibodiesIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Fc gamma receptor IIBIBA 01/2018
1	Saline SolutionIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 11/2016
1	trichlorosucrose (sucralose)IBA 11/2016
1	Amphotericin B (Amphotericin)FDA LinkGeneric 08/2015
1	4-O-carboxymethylascochlorinIBA 08/2015
1	galactomannanIBA 05/2015
1	IronIBA 01/2015
1	Chelating AgentsIBA 01/2015
1	Voriconazole (Vfend)FDA LinkGeneric 11/2014

Therapy/Procedure

5	Therapeutics 03/2022 - 01/2015
5	Punctures 01/2018 - 08/2015
5	Ligation 01/2018 - 08/2015
3	Oral Administration 01/2020 - 11/2016
2	Immunotherapy 01/2020 - 01/2015
1	Aftercare (After-Treatment) 10/2020
1	Salvage Therapy 11/2019
1	Catheters 07/2016
1	Peritoneal Dialysis 05/2015